Australia
Immunicum AB, announced that its Annual Report for 2018 is now available on the company’s website, www.immunicum.com.
The artificial womb technology was able to maintain extremely preterm lamb fetuses, which were equivalent to a human fetus at 24 weeks of gestation.
Clinical Network Services USA, an integrated services group focused on clinical product development and subsidiary of Asia-Pacific specialist CRO Novotech, announced the appointment of Dr Robert Malone as Principal Consultant in its Washington D.C. office.
Koligo Therapeutics a regenerative medicine and 3D bio-printing company to list on the ASX under the stock ticker “KOL”.
Aphria Inc. President, Jakob Ripshtein, is proposed to replace Mr Battersby as Non-Executive Director (pending ODC approval)
Life sciences company eSense-Lab Ltd is pleased to report its preliminary financial results for the year ending 31 December 2018, along with the attached Appendix 4E.
The rotavirus vaccine may be pulling double duty; it not only protects young children against a potentially life-threatening rotavirus infection but may also reduce their likelihood of developing type 1 diabetes.
Medical technology company Admedus Ltd is pleased to advise that interim data from the animal study of its single-piece 3D aortic valve suggest that the device can be implanted safely and has the potential to deliver meaningful clinical benefits.
Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.
Philadelphia PA and Sydney Australia, 12 February 2019: Medical dermatology company Botanix Pharmaceuticals Limited is pleased to announce the appointment of Dr Michael Thurn, Head of Australian Operations, as Executive Director.
PRESS RELEASES